Healthcare -
Biotechnology - NASDAQ - US
$ 85.3
-2.88 %
$ 10.6 B
Market Cap
-18.87
P/E
PCVX - SHORT-TERM DEBT
Short-term Debt PCVX - Vaxcyte, Inc.
7.11 M
LAST VALUE
-17.90%
2 YEAR CAGR
88.74%
5 YEAR CAGR
0.00%
10 YEAR CAGR